Abstract
WCN24-1063 The role of sodium-glucose cotransporter 2 (SGLT2) inhibitors in Diabetic Nephropathy and Non Diabetic Renal Disease in Diabetes Mellitus type2 Patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have